194 related articles for article (PubMed ID: 27775079)
21. Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.
Huang GH; Xu QF; Cui YH; Li N; Bian XW; Lv SQ
Cancer Sci; 2016 May; 107(5):583-9. PubMed ID: 27171351
[TBL] [Abstract][Full Text] [Related]
22. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
24. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
[TBL] [Abstract][Full Text] [Related]
25. Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model.
Dave B; Landis MD; Tweardy DJ; Chang JC; Dobrolecki LE; Wu MF; Zhang X; Westbrook TF; Hilsenbeck SG; Liu D; Lewis MT
PLoS One; 2012; 7(8):e30207. PubMed ID: 22879872
[TBL] [Abstract][Full Text] [Related]
26. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.
Lim KJ; Bisht S; Bar EE; Maitra A; Eberhart CG
Cancer Biol Ther; 2011 Mar; 11(5):464-73. PubMed ID: 21193839
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
28. Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling.
Nazio F; Po A; Abballe L; Ballabio C; Diomedi Camassei F; Bordi M; Camera A; Caruso S; Caruana I; Pezzullo M; Ferraina C; Milletti G; Gianesello M; Reddel S; De Luca CD; Ceglie D; Marinelli S; Campello S; Papaleo E; Miele E; Cacchione A; Carai A; Vinci M; Velardi E; De Angelis B; Tiberi L; Quintarelli C; Mastronuzzi A; Ferretti E; Locatelli F; Cecconi F
Acta Neuropathol; 2021 Sep; 142(3):537-564. PubMed ID: 34302498
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
[TBL] [Abstract][Full Text] [Related]
30. LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.
Chen X; Pan L; Wei J; Zhang R; Yang X; Song J; Bai RY; Fu S; Pierson CR; Finlay JL; Li C; Lin J
Sci Rep; 2021 Mar; 11(1):6517. PubMed ID: 33753770
[TBL] [Abstract][Full Text] [Related]
31. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG
Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340
[TBL] [Abstract][Full Text] [Related]
32. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
33. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.
Segatto I; Berton S; Sonego M; Massarut S; Perin T; Piccoli E; Colombatti A; Vecchione A; Baldassarre G; Belletti B
Oncotarget; 2014 Aug; 5(15):6267-79. PubMed ID: 25026286
[TBL] [Abstract][Full Text] [Related]
34. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
[TBL] [Abstract][Full Text] [Related]
35. Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line.
de la Rosa J; Sáenz Antoñanzas A; Shahi MH; Meléndez B; Rey JA; Castresana JS
Tumour Biol; 2016 Sep; 37(9):12359-12370. PubMed ID: 27306215
[TBL] [Abstract][Full Text] [Related]
36. Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion.
Liu H; Sun Y; O'Brien JA; Franco-Barraza J; Qi X; Yuan H; Jin W; Zhang J; Gu C; Zhao Z; Yu C; Feng S; Yu X
Neuro Oncol; 2020 May; 22(5):625-638. PubMed ID: 31729527
[TBL] [Abstract][Full Text] [Related]
37. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
[TBL] [Abstract][Full Text] [Related]
40. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
